rs373597946

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_ModerateBP6BP7

The NM_000334.4(SCN4A):​c.3429C>T​(p.Phe1143Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000341 in 1,471,820 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 1 hom. )

Consequence

SCN4A
NM_000334.4 synonymous

Scores

3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 0.620

Publications

0 publications found
Variant links:
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
SCN4A Gene-Disease associations (from GenCC):
  • hyperkalemic periodic paralysis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P
  • paramyotonia congenita of Von Eulenburg
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • SCN4A-related myopathy, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Illumina, ClinGen
  • hypokalemic periodic paralysis, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • potassium-aggravated myotonia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 16
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • congenital myopathy
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital myopathy 22A, classic
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acetazolamide-responsive myotonia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia fluctuans
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia permanens
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000334.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 17-63947057-G-A is Benign according to our data. Variant chr17-63947057-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 255848.
BP7
Synonymous conserved (PhyloP=0.62 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000334.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
NM_000334.4
MANE Select
c.3429C>Tp.Phe1143Phe
synonymous
Exon 18 of 24NP_000325.4P35499

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
ENST00000435607.3
TSL:1 MANE Select
c.3429C>Tp.Phe1143Phe
synonymous
Exon 18 of 24ENSP00000396320.1P35499

Frequencies

GnomAD3 genomes
AF:
0.000374
AC:
55
AN:
147252
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000247
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00234
Gnomad EAS
AF:
0.000219
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000516
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000569
Gnomad OTH
AF:
0.000974
GnomAD2 exomes
AF:
0.000361
AC:
89
AN:
246656
AF XY:
0.000351
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00210
Gnomad EAS exome
AF:
0.000224
Gnomad FIN exome
AF:
0.000237
Gnomad NFE exome
AF:
0.000512
Gnomad OTH exome
AF:
0.000333
GnomAD4 exome
AF:
0.000337
AC:
447
AN:
1324568
Hom.:
1
Cov.:
36
AF XY:
0.000370
AC XY:
243
AN XY:
657446
show subpopulations
African (AFR)
AF:
0.000171
AC:
5
AN:
29286
American (AMR)
AF:
0.0000247
AC:
1
AN:
40462
Ashkenazi Jewish (ASJ)
AF:
0.00282
AC:
59
AN:
20938
East Asian (EAS)
AF:
0.000103
AC:
3
AN:
29088
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84874
European-Finnish (FIN)
AF:
0.000344
AC:
14
AN:
40678
Middle Eastern (MID)
AF:
0.000826
AC:
4
AN:
4840
European-Non Finnish (NFE)
AF:
0.000342
AC:
350
AN:
1023492
Other (OTH)
AF:
0.000216
AC:
11
AN:
50910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000374
AC:
55
AN:
147252
Hom.:
0
Cov.:
32
AF XY:
0.000376
AC XY:
27
AN XY:
71828
show subpopulations
African (AFR)
AF:
0.0000247
AC:
1
AN:
40470
American (AMR)
AF:
0.00
AC:
0
AN:
14824
Ashkenazi Jewish (ASJ)
AF:
0.00234
AC:
8
AN:
3422
East Asian (EAS)
AF:
0.000219
AC:
1
AN:
4568
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4208
European-Finnish (FIN)
AF:
0.000516
AC:
5
AN:
9698
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.000569
AC:
38
AN:
66820
Other (OTH)
AF:
0.000974
AC:
2
AN:
2054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000574
Hom.:
0
Bravo
AF:
0.000295
EpiCase
AF:
0.000382
EpiControl
AF:
0.000653

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hyperkalemic periodic paralysis (2)
-
-
2
not specified (2)
-
1
-
Congenital myasthenic syndrome 16 (1)
-
-
1
Hypokalemic periodic paralysis, type 2 (1)
-
-
1
not provided (1)
-
-
1
Paramyotonia congenita of Von Eulenburg (1)
-
-
1
Potassium-aggravated myotonia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
9.0
DANN
Benign
0.91
PhyloP100
0.62
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs373597946;
hg19: chr17-62024417;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.